Quality of life and gut health in children with cystic fibrosis
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study looks at how a drug called ETI (a combination of three medicines) affects the quality of life and gut health of children with cystic fibrosis. If you or your child has the right type of CF and is between 2 and 18 years old, this trial may help us understand how treatment improves daily life and digestion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cystic fibrosis (CF) and your specific CF gene type can be treated with the drug ETI (elexacaftor/tezacaftor/ivacaftor).
- You are between 2 and 18 years old.
- You are part of the Norwegian CF Registry and have agreed to take part in the CF research biobank.
- You have not used any other CFTR modulator drugs in the last 6 months.
- You have not used probiotics or prebiotics in the last 2 months.
- You do not currently have a lung infection (pulmonary exacerbation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at sinus problems in young children with cystic fibrosis. One group of children starts a new medicine called a highly effective modulator (like Trikafta), and the other group does not take this medicine. The goal is to see how the medicine affects sinus health over time.
This study follows children with cystic fibrosis (CF) and healthy infants over time to understand how CF changes in the modern era of care. It collects health information and tests to learn more about the disease and help improve future treatments.
This study looks at how a child’s early lung function, viral infections, and gut (microbiome) changes affect cystic fibrosis over time. It may help doctors understand what predicts how lung disease develops, which could improve future care.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
This study tests whether a Mediterranean-style diet can improve gastrointestinal health in children with cystic fibrosis. It requires families to follow the diet for 6 months and attend regular clinic visits.
This study enrolls newly diagnosed infants with cystic fibrosis to follow them during “precision medicine” care. It may help doctors better understand which treatments and monitoring work best, especially before certain infections develop.
Hear when a new Cystic Fibrosis in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.